These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1416865)

  • 1. Effects of squalene epoxidase inhibitors on Candida albicans.
    Georgopapadakou NH; Bertasso A
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1779-81. PubMed ID: 1416865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate.
    Ryder NS; Frank I; Dupont MC
    Antimicrob Agents Chemother; 1986 May; 29(5):858-60. PubMed ID: 3524433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents.
    Favre B; Ryder NS
    Antimicrob Agents Chemother; 1996 Feb; 40(2):443-7. PubMed ID: 8834895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mode of antifungal action of tolnaftate.
    Barrett-Bee KJ; Lane AC; Turner RW
    J Med Vet Mycol; 1986 Apr; 24(2):155-60. PubMed ID: 3522841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terbinafine: mode of action and properties of the squalene epoxidase inhibition.
    Ryder NS
    Br J Dermatol; 1992 Feb; 126 Suppl 39():2-7. PubMed ID: 1543672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition of fungal amd mammalian squalene epoxidases by the benzylamine SDZ SBA 586 in comparison with the allylamine terbinafine.
    Favre B; Ryder NS
    Arch Biochem Biophys; 1997 Apr; 340(2):265-9. PubMed ID: 9143330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
    Sanati H; Belanger P; Fratti R; Ghannoum M
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans.
    Georgopapadakou NH; Dix BA; Smith SA; Freudenberger J; Funke PT
    Antimicrob Agents Chemother; 1987 Jan; 31(1):46-51. PubMed ID: 3551826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of fungal and mammalian sterol biosynthesis by 2-aza-2,3-dihydrosqualene.
    Ryder NS; Dupont MC; Frank I
    FEBS Lett; 1986 Aug; 204(2):239-42. PubMed ID: 3525224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action and biochemical selectivity of allylamine antimycotic agents.
    Ryder NS
    Ann N Y Acad Sci; 1988; 544():208-20. PubMed ID: 3063168
    [No Abstract]   [Full Text] [Related]  

  • 11. Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent.
    Ryder NS
    Antimicrob Agents Chemother; 1985 Feb; 27(2):252-6. PubMed ID: 4039119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans.
    Ryder NS; Seidl G; Troke PF
    Antimicrob Agents Chemother; 1984 Apr; 25(4):483-7. PubMed ID: 6375557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of terbinafine-resistant Trichophyton rubrum isolates.
    Favre B; Ghannoum MA; Ryder NS
    Med Mycol; 2004 Dec; 42(6):525-9. PubMed ID: 15682641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antifungal agents on ergosterol biosynthesis in Candida albicans and Trichophyton mentagrophytes: differential inhibitory sites of naphthiomate and miconazole.
    Morita T; Nozawa Y
    J Invest Dermatol; 1985 Nov; 85(5):434-7. PubMed ID: 3902987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of anti-Candida drugs: focus on terconazole and other ergosterol biosynthesis inhibitors.
    Vanden Bossche H; Marichal P
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1193-9. PubMed ID: 1951574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-azole inhibitor of lanosterol 14 alpha-methyl demethylase in Candida albicans.
    Capobianco JO; Doran CC; Goldman RC; De B
    J Antimicrob Chemother; 1992 Dec; 30(6):781-90. PubMed ID: 1289352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymes.
    Ryder NS; Dupont MC
    Biochem J; 1985 Sep; 230(3):765-70. PubMed ID: 3877503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel sequence element is involved in the transcriptional regulation of expression of the ERG1 (squalene epoxidase) gene in Saccharomyces cerevisiae.
    Leber R; Zenz R; Schröttner K; Fuchsbichler S; Pühringer B; Turnowsky F
    Eur J Biochem; 2001 Feb; 268(4):914-24. PubMed ID: 11179957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibitory effects of protoberberines on sterol and chitin biosyntheses in Candida albicans.
    Park KS; Kang KC; Kim JH; Adams DJ; Johng TN; Paik YK
    J Antimicrob Chemother; 1999 May; 43(5):667-74. PubMed ID: 10382888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans.
    Pasrija R; Krishnamurthy S; Prasad T; Ernst JF; Prasad R
    J Antimicrob Chemother; 2005 Jun; 55(6):905-13. PubMed ID: 15845783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.